Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

10.59
BATS BZX Real-Time Price
As of 9:44am ET
 +0.19 / +1.83%
Today’s Change
7.12
Today|||52-Week Range
11.85
+5.37%
Year-to-Date
Opko Health: Rayaldee Makes This Stock Worth Watching
Dec 01 / MotleyFool.com - Paid Partner Content
5 Biotech Stocks George Soros Is Buying
Nov 22 / MotleyFool.com - Paid Partner Content
OPKO Health (OPK) Launches Kidney Drug Rayaldee in U.S.
Nov 25 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close10.40
Today’s open10.52
Day’s range10.47 - 10.59
Volume9,063
Average volume (3 months)3,299,944
Market cap$5.8B
Dividend yield--
Data as of 9:44am ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-40.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratioNM
Price/Sales9.97
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-0.18-0.34%
JAZZJazz Pharmaceuticals...+1.89+1.85%
UTHRUnited Therapeutics ...+1.80+1.42%
VRXValeant Pharmaceutic...+0.10+0.65%
Data as of 9:45am ET, 12/05/2016

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts


Search for Jobs